Pharma and Healthcare Dealtracker: Q3 2023
Thought LeadershipThis publication covers the performance of the pharma and healthcare sector in Q3.
For more updates follow Grant Thornton Bharat on WhatsApp

November 2023 recorded the second-highest monthly values for the year, with 132 deals amounting to USD 6.5 billion. The surge in values was propelled by a one-billion-dollar deal and nine high-value deals (those valued over USD 100 million). The month recorded a 21% decline in volumes compared to October 2023. M&A deals this month observed the highest values for the year, totalling USD 4.4 billion, with only 51 deals, accounting for a 7.7x growth in values over the previous month. While there was a 28% decline in PE volumes compared to October 2023, the values stood unchanged. Traditional sectors, particularly energy and natural resources, pharma, and banking, led in terms of deal values, with a 74% share, while start-up, e-commerce, and pharma led in terms of volumes, with a 58% share. The biggest deal of the month was Siemens AG, which increased its stake in Siemens Ltd to 69% for a value of USD 2.28 billion to support the stability of Siemens Energy. This deal was responsible for 35% of the month’s overall values.
This publication covers the performance of the pharma and healthcare sector in Q3.
This publication covers the performance of the technology sector in Q3.
This publication covers the performance of the BFSI sector in Q3.